Loading…

Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma

Hepatitis B virus X protein (HBx) is involved in the pathogenesis of hepatocellular carcinoma (HCC). Overexpression of the transcripts from the P3 and P4 promoters of the insulin-like growth factor-II (IGF-II) gene is observed in HCC. The present study investigated the involvement of HBx in IGF-II o...

Full description

Saved in:
Bibliographic Details
Published in:American journal of cancer research 2015-01, Vol.5 (3), p.956-978
Main Authors: Liu, Xu You, Tang, Shao Hui, Wu, Sheng Lan, Luo, Yu Hong, Cao, Ming Rong, Zhou, Hong Ke, Jiang, Xiang Wu, Shu, Jian Chang, Bie, Cai Qun, Huang, Si Min, Zheng, Zhan Hong, Gao, Fei
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 978
container_issue 3
container_start_page 956
container_title American journal of cancer research
container_volume 5
creator Liu, Xu You
Tang, Shao Hui
Wu, Sheng Lan
Luo, Yu Hong
Cao, Ming Rong
Zhou, Hong Ke
Jiang, Xiang Wu
Shu, Jian Chang
Bie, Cai Qun
Huang, Si Min
Zheng, Zhan Hong
Gao, Fei
description Hepatitis B virus X protein (HBx) is involved in the pathogenesis of hepatocellular carcinoma (HCC). Overexpression of the transcripts from the P3 and P4 promoters of the insulin-like growth factor-II (IGF-II) gene is observed in HCC. The present study investigated the involvement of HBx in IGF-II overexpression and its epigenetic regulation. Firstly, the effects of HBx on P3 and P4 mRNA expression, the methylation status of the P3 and P4 promoters, and MBD2 expression were analyzed in human HCC cells and HCC samples. Next, interaction between HBx and MBD2 or CBP/p300 was assessed by co-immunoprecipitation, and HBx-mediated binding of MBD2 and CBP/p300 to the P3 and P4 promoters and the acetylation of the corresponding histones H3 and H4 were evaluated by quantitative chromatin immunoprecipitation. Finally, using siRNA knockdown, we investigated the roles of MBD2 and CBP/p300 in IGF-II overexpression and its epigenetic regulation. Our results showed that HBx promotes IGF-II expression via inducing the hypomethylation of the P3 and P4 promoters, and that HBx increases MBD2 expression, directly interacts with MBD2 and CBP/p300, and elevates their recruitment to the hypomethylated P3 and P4 promoters with increased acetylation levels of the corresponding histones H3 and H4. Further results showed that endogenous MBD2 and CBP/p300 are necessary for HBx-induced IGF-II overexpression and that CBP/p300 presence and CBP/p300-mediated acetylation of histones H3 and H4 are partially required for MBD2 binding and its demethylase activity. These data suggest that HBx induces MBD2-HBx-CBP/p300 complex formation via interaction with MBD2 and CBP/p300, which contributes to the hypomethylation and transcriptional activation of the IGF-II-P3 and P4 promoters and that CBP/p300-mediated acetylation of histones H3 and H4 may be a rate-limiting step for the hypomethylation and activation of these two promoters. This study provides an alternative mechanism for understanding the pathogenesis of HBx-mediated HCC.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4449429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1686414577</sourcerecordid><originalsourceid>FETCH-LOGICAL-p196t-5c7f6686448490776c82f61ba817d2b546ca5ed5a41ea81093d379c910baf313</originalsourceid><addsrcrecordid>eNpVUMFOwzAMrRCITWO_gHLkUqlp06S5IME0YNIkLjtwq9LU3QJpUpJ0sBufvk4baPhiy-_5PdsX0TjFOY0pZ_TyrB5FU-_fkyFIgjnh19EopQnJeZGMo595p9ZgICiJWlv3WgRlDbINUsb3WplYqw9Aa2e_wgY1Qgbr4sUC2S04-O4ceH_gVzu0gW6YDcqjR7RVrvfoDXXOBlBm0DrCVoLWg4dDUjipjG3FTXTVCO1hesqTaPU0X81e4uXr82L2sIw7zGmIc8kaSgtKSEF4whiVRdpQXIkCszqtckKlyKHOBcEw9BKe1RnjkuOkEk2Gs0l0f5Tt-qqFWoIJTuiyc6oVbldaocr_iFGbcm23JSGEk5QPAncnAWc_e_ChbJU_nCMM2N6X-LAcJjljA_X23OvP5Pfr2R6xSoOf</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1686414577</pqid></control><display><type>article</type><title>Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma</title><source>PubMed Central</source><creator>Liu, Xu You ; Tang, Shao Hui ; Wu, Sheng Lan ; Luo, Yu Hong ; Cao, Ming Rong ; Zhou, Hong Ke ; Jiang, Xiang Wu ; Shu, Jian Chang ; Bie, Cai Qun ; Huang, Si Min ; Zheng, Zhan Hong ; Gao, Fei</creator><creatorcontrib>Liu, Xu You ; Tang, Shao Hui ; Wu, Sheng Lan ; Luo, Yu Hong ; Cao, Ming Rong ; Zhou, Hong Ke ; Jiang, Xiang Wu ; Shu, Jian Chang ; Bie, Cai Qun ; Huang, Si Min ; Zheng, Zhan Hong ; Gao, Fei</creatorcontrib><description>Hepatitis B virus X protein (HBx) is involved in the pathogenesis of hepatocellular carcinoma (HCC). Overexpression of the transcripts from the P3 and P4 promoters of the insulin-like growth factor-II (IGF-II) gene is observed in HCC. The present study investigated the involvement of HBx in IGF-II overexpression and its epigenetic regulation. Firstly, the effects of HBx on P3 and P4 mRNA expression, the methylation status of the P3 and P4 promoters, and MBD2 expression were analyzed in human HCC cells and HCC samples. Next, interaction between HBx and MBD2 or CBP/p300 was assessed by co-immunoprecipitation, and HBx-mediated binding of MBD2 and CBP/p300 to the P3 and P4 promoters and the acetylation of the corresponding histones H3 and H4 were evaluated by quantitative chromatin immunoprecipitation. Finally, using siRNA knockdown, we investigated the roles of MBD2 and CBP/p300 in IGF-II overexpression and its epigenetic regulation. Our results showed that HBx promotes IGF-II expression via inducing the hypomethylation of the P3 and P4 promoters, and that HBx increases MBD2 expression, directly interacts with MBD2 and CBP/p300, and elevates their recruitment to the hypomethylated P3 and P4 promoters with increased acetylation levels of the corresponding histones H3 and H4. Further results showed that endogenous MBD2 and CBP/p300 are necessary for HBx-induced IGF-II overexpression and that CBP/p300 presence and CBP/p300-mediated acetylation of histones H3 and H4 are partially required for MBD2 binding and its demethylase activity. These data suggest that HBx induces MBD2-HBx-CBP/p300 complex formation via interaction with MBD2 and CBP/p300, which contributes to the hypomethylation and transcriptional activation of the IGF-II-P3 and P4 promoters and that CBP/p300-mediated acetylation of histones H3 and H4 may be a rate-limiting step for the hypomethylation and activation of these two promoters. This study provides an alternative mechanism for understanding the pathogenesis of HBx-mediated HCC.</description><identifier>ISSN: 2156-6976</identifier><identifier>EISSN: 2156-6976</identifier><identifier>PMID: 26045980</identifier><language>eng</language><publisher>United States: e-Century Publishing Corporation</publisher><subject>Original</subject><ispartof>American journal of cancer research, 2015-01, Vol.5 (3), p.956-978</ispartof><rights>AJCR Copyright © 2015 2015</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449429/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449429/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26045980$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Xu You</creatorcontrib><creatorcontrib>Tang, Shao Hui</creatorcontrib><creatorcontrib>Wu, Sheng Lan</creatorcontrib><creatorcontrib>Luo, Yu Hong</creatorcontrib><creatorcontrib>Cao, Ming Rong</creatorcontrib><creatorcontrib>Zhou, Hong Ke</creatorcontrib><creatorcontrib>Jiang, Xiang Wu</creatorcontrib><creatorcontrib>Shu, Jian Chang</creatorcontrib><creatorcontrib>Bie, Cai Qun</creatorcontrib><creatorcontrib>Huang, Si Min</creatorcontrib><creatorcontrib>Zheng, Zhan Hong</creatorcontrib><creatorcontrib>Gao, Fei</creatorcontrib><title>Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma</title><title>American journal of cancer research</title><addtitle>Am J Cancer Res</addtitle><description>Hepatitis B virus X protein (HBx) is involved in the pathogenesis of hepatocellular carcinoma (HCC). Overexpression of the transcripts from the P3 and P4 promoters of the insulin-like growth factor-II (IGF-II) gene is observed in HCC. The present study investigated the involvement of HBx in IGF-II overexpression and its epigenetic regulation. Firstly, the effects of HBx on P3 and P4 mRNA expression, the methylation status of the P3 and P4 promoters, and MBD2 expression were analyzed in human HCC cells and HCC samples. Next, interaction between HBx and MBD2 or CBP/p300 was assessed by co-immunoprecipitation, and HBx-mediated binding of MBD2 and CBP/p300 to the P3 and P4 promoters and the acetylation of the corresponding histones H3 and H4 were evaluated by quantitative chromatin immunoprecipitation. Finally, using siRNA knockdown, we investigated the roles of MBD2 and CBP/p300 in IGF-II overexpression and its epigenetic regulation. Our results showed that HBx promotes IGF-II expression via inducing the hypomethylation of the P3 and P4 promoters, and that HBx increases MBD2 expression, directly interacts with MBD2 and CBP/p300, and elevates their recruitment to the hypomethylated P3 and P4 promoters with increased acetylation levels of the corresponding histones H3 and H4. Further results showed that endogenous MBD2 and CBP/p300 are necessary for HBx-induced IGF-II overexpression and that CBP/p300 presence and CBP/p300-mediated acetylation of histones H3 and H4 are partially required for MBD2 binding and its demethylase activity. These data suggest that HBx induces MBD2-HBx-CBP/p300 complex formation via interaction with MBD2 and CBP/p300, which contributes to the hypomethylation and transcriptional activation of the IGF-II-P3 and P4 promoters and that CBP/p300-mediated acetylation of histones H3 and H4 may be a rate-limiting step for the hypomethylation and activation of these two promoters. This study provides an alternative mechanism for understanding the pathogenesis of HBx-mediated HCC.</description><subject>Original</subject><issn>2156-6976</issn><issn>2156-6976</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVUMFOwzAMrRCITWO_gHLkUqlp06S5IME0YNIkLjtwq9LU3QJpUpJ0sBufvk4baPhiy-_5PdsX0TjFOY0pZ_TyrB5FU-_fkyFIgjnh19EopQnJeZGMo595p9ZgICiJWlv3WgRlDbINUsb3WplYqw9Aa2e_wgY1Qgbr4sUC2S04-O4ceH_gVzu0gW6YDcqjR7RVrvfoDXXOBlBm0DrCVoLWg4dDUjipjG3FTXTVCO1hesqTaPU0X81e4uXr82L2sIw7zGmIc8kaSgtKSEF4whiVRdpQXIkCszqtckKlyKHOBcEw9BKe1RnjkuOkEk2Gs0l0f5Tt-qqFWoIJTuiyc6oVbldaocr_iFGbcm23JSGEk5QPAncnAWc_e_ChbJU_nCMM2N6X-LAcJjljA_X23OvP5Pfr2R6xSoOf</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Liu, Xu You</creator><creator>Tang, Shao Hui</creator><creator>Wu, Sheng Lan</creator><creator>Luo, Yu Hong</creator><creator>Cao, Ming Rong</creator><creator>Zhou, Hong Ke</creator><creator>Jiang, Xiang Wu</creator><creator>Shu, Jian Chang</creator><creator>Bie, Cai Qun</creator><creator>Huang, Si Min</creator><creator>Zheng, Zhan Hong</creator><creator>Gao, Fei</creator><general>e-Century Publishing Corporation</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma</title><author>Liu, Xu You ; Tang, Shao Hui ; Wu, Sheng Lan ; Luo, Yu Hong ; Cao, Ming Rong ; Zhou, Hong Ke ; Jiang, Xiang Wu ; Shu, Jian Chang ; Bie, Cai Qun ; Huang, Si Min ; Zheng, Zhan Hong ; Gao, Fei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p196t-5c7f6686448490776c82f61ba817d2b546ca5ed5a41ea81093d379c910baf313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Liu, Xu You</creatorcontrib><creatorcontrib>Tang, Shao Hui</creatorcontrib><creatorcontrib>Wu, Sheng Lan</creatorcontrib><creatorcontrib>Luo, Yu Hong</creatorcontrib><creatorcontrib>Cao, Ming Rong</creatorcontrib><creatorcontrib>Zhou, Hong Ke</creatorcontrib><creatorcontrib>Jiang, Xiang Wu</creatorcontrib><creatorcontrib>Shu, Jian Chang</creatorcontrib><creatorcontrib>Bie, Cai Qun</creatorcontrib><creatorcontrib>Huang, Si Min</creatorcontrib><creatorcontrib>Zheng, Zhan Hong</creatorcontrib><creatorcontrib>Gao, Fei</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Xu You</au><au>Tang, Shao Hui</au><au>Wu, Sheng Lan</au><au>Luo, Yu Hong</au><au>Cao, Ming Rong</au><au>Zhou, Hong Ke</au><au>Jiang, Xiang Wu</au><au>Shu, Jian Chang</au><au>Bie, Cai Qun</au><au>Huang, Si Min</au><au>Zheng, Zhan Hong</au><au>Gao, Fei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma</atitle><jtitle>American journal of cancer research</jtitle><addtitle>Am J Cancer Res</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>5</volume><issue>3</issue><spage>956</spage><epage>978</epage><pages>956-978</pages><issn>2156-6976</issn><eissn>2156-6976</eissn><abstract>Hepatitis B virus X protein (HBx) is involved in the pathogenesis of hepatocellular carcinoma (HCC). Overexpression of the transcripts from the P3 and P4 promoters of the insulin-like growth factor-II (IGF-II) gene is observed in HCC. The present study investigated the involvement of HBx in IGF-II overexpression and its epigenetic regulation. Firstly, the effects of HBx on P3 and P4 mRNA expression, the methylation status of the P3 and P4 promoters, and MBD2 expression were analyzed in human HCC cells and HCC samples. Next, interaction between HBx and MBD2 or CBP/p300 was assessed by co-immunoprecipitation, and HBx-mediated binding of MBD2 and CBP/p300 to the P3 and P4 promoters and the acetylation of the corresponding histones H3 and H4 were evaluated by quantitative chromatin immunoprecipitation. Finally, using siRNA knockdown, we investigated the roles of MBD2 and CBP/p300 in IGF-II overexpression and its epigenetic regulation. Our results showed that HBx promotes IGF-II expression via inducing the hypomethylation of the P3 and P4 promoters, and that HBx increases MBD2 expression, directly interacts with MBD2 and CBP/p300, and elevates their recruitment to the hypomethylated P3 and P4 promoters with increased acetylation levels of the corresponding histones H3 and H4. Further results showed that endogenous MBD2 and CBP/p300 are necessary for HBx-induced IGF-II overexpression and that CBP/p300 presence and CBP/p300-mediated acetylation of histones H3 and H4 are partially required for MBD2 binding and its demethylase activity. These data suggest that HBx induces MBD2-HBx-CBP/p300 complex formation via interaction with MBD2 and CBP/p300, which contributes to the hypomethylation and transcriptional activation of the IGF-II-P3 and P4 promoters and that CBP/p300-mediated acetylation of histones H3 and H4 may be a rate-limiting step for the hypomethylation and activation of these two promoters. This study provides an alternative mechanism for understanding the pathogenesis of HBx-mediated HCC.</abstract><cop>United States</cop><pub>e-Century Publishing Corporation</pub><pmid>26045980</pmid><tpages>23</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2156-6976
ispartof American journal of cancer research, 2015-01, Vol.5 (3), p.956-978
issn 2156-6976
2156-6976
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4449429
source PubMed Central
subjects Original
title Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A14%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epigenetic%20modulation%20of%20insulin-like%20growth%20factor-II%20overexpression%20by%20hepatitis%20B%20virus%20X%20protein%20in%20hepatocellular%20carcinoma&rft.jtitle=American%20journal%20of%20cancer%20research&rft.au=Liu,%20Xu%20You&rft.date=2015-01-01&rft.volume=5&rft.issue=3&rft.spage=956&rft.epage=978&rft.pages=956-978&rft.issn=2156-6976&rft.eissn=2156-6976&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1686414577%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p196t-5c7f6686448490776c82f61ba817d2b546ca5ed5a41ea81093d379c910baf313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1686414577&rft_id=info:pmid/26045980&rfr_iscdi=true